FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308694345> ?p ?o ?g. }

• W4308694345 endingPage "4749" @default.
• W4308694345 startingPage "4749" @default.
• W4308694345 abstract "It is not fully understood how supplementation with omega-3 fatty acids affects the metabolism of amino acids required for the bioavailability/synthesis of NO, i.e., L-arginine (L-arg), asymmetric dimethylarginine (ADMA), their metabolites, and the L-arg/ADMA ratio and their impact on running economy (RE) in runners. Thus, 26 male amateur endurance runners completed a twelve-week study in which they were divided into two supplemented groups: the OMEGA group (n = 14; 2234 mg and 916 mg of eicosapentaenoic and docosahexaenoic acid daily) or the MCT group (n = 12; 4000 mg of medium-chain triglycerides daily). At the same time, all participants followed an endurance training program. Before and after the 12-week intervention, blood was collected from participants at two time points (at rest and immediately post-exercise) to determine EPA and DHA in red blood cells (RBCs) and plasma levels of L-arg, ADMA, and their metabolites. RBC EPA and DHA significantly increased in the OMEGA group (p < 0.001), which was related to the resting increase in L-arg (p = 0.001) and in the L-arg/ADMA ratio (p = 0.005) with no changes in the MCT group. No differences were found in post-exercise amino acid levels. A total of 12 weeks of omega-3 fatty acid supplementation at a dose of 2234 mg of EPA and 916 mg of DHA daily increased levels of L-arg and the L-arg/ADMA ratio, which indirectly indicates increased bioavailability/NO synthesis. However, these changes were not associated with improved RE in male amateur endurance runners." @default.
• W4308694345 created "2022-11-14" @default.
• W4308694345 creator A5001740107 @default.
• W4308694345 creator A5027988470 @default.
• W4308694345 creator A5028066936 @default.
• W4308694345 creator A5033733044 @default.
• W4308694345 creator A5066362474 @default.
• W4308694345 creator A5066685320 @default.
• W4308694345 creator A5074645101 @default.
• W4308694345 date "2022-11-10" @default.
• W4308694345 modified "2023-09-25" @default.
• W4308694345 title "Increased Plasma L-Arginine Levels and L-Arginine/ADMA Ratios after Twelve Weeks of Omega-3 Fatty Acid Supplementation in Amateur Male Endurance Runners" @default.
• W4308694345 cites W1572120598 @default.
• W4308694345 cites W1972806009 @default.
• W4308694345 cites W1979240894 @default.
• W4308694345 cites W1981493487 @default.
• W4308694345 cites W1987068861 @default.
• W4308694345 cites W1988600687 @default.
• W4308694345 cites W1990176711 @default.
• W4308694345 cites W1995528647 @default.
• W4308694345 cites W1997640957 @default.
• W4308694345 cites W1997935568 @default.
• W4308694345 cites W2006574739 @default.
• W4308694345 cites W2036304270 @default.
• W4308694345 cites W2049025003 @default.
• W4308694345 cites W2054949240 @default.
• W4308694345 cites W2058385357 @default.
• W4308694345 cites W2080105057 @default.
• W4308694345 cites W2081497223 @default.
• W4308694345 cites W2081514890 @default.
• W4308694345 cites W2085191848 @default.
• W4308694345 cites W2087937365 @default.
• W4308694345 cites W2095187945 @default.
• W4308694345 cites W2106072139 @default.
• W4308694345 cites W2123400890 @default.
• W4308694345 cites W2131620744 @default.
• W4308694345 cites W2145414873 @default.
• W4308694345 cites W2145802142 @default.
• W4308694345 cites W2159917802 @default.
• W4308694345 cites W2169002600 @default.
• W4308694345 cites W2313326603 @default.
• W4308694345 cites W2766185642 @default.
• W4308694345 cites W2888009838 @default.
• W4308694345 cites W2970905964 @default.
• W4308694345 cites W2983274306 @default.
• W4308694345 cites W3011486762 @default.
• W4308694345 cites W3019970335 @default.
• W4308694345 cites W3027588140 @default.
• W4308694345 cites W3095825231 @default.
• W4308694345 cites W3111386977 @default.
• W4308694345 cites W3125704250 @default.
• W4308694345 cites W3159064684 @default.
• W4308694345 cites W3162316168 @default.
• W4308694345 cites W3169602632 @default.
• W4308694345 cites W3197071922 @default.
• W4308694345 cites W3200262438 @default.
• W4308694345 cites W4210729677 @default.
• W4308694345 cites W4210820929 @default.
• W4308694345 cites W4297093810 @default.
• W4308694345 doi "https://doi.org/10.3390/nu14224749" @default.
• W4308694345 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36432437" @default.
• W4308694345 hasPublicationYear "2022" @default.
• W4308694345 type Work @default.
• W4308694345 citedByCount "0" @default.
• W4308694345 crossrefType "journal-article" @default.
• W4308694345 hasAuthorship W4308694345A5001740107 @default.
• W4308694345 hasAuthorship W4308694345A5027988470 @default.
• W4308694345 hasAuthorship W4308694345A5028066936 @default.
• W4308694345 hasAuthorship W4308694345A5033733044 @default.
• W4308694345 hasAuthorship W4308694345A5066362474 @default.
• W4308694345 hasAuthorship W4308694345A5066685320 @default.
• W4308694345 hasAuthorship W4308694345A5074645101 @default.
• W4308694345 hasBestOaLocation W43086943451 @default.
• W4308694345 hasConcept C126322002 @default.
• W4308694345 hasConcept C134018914 @default.
• W4308694345 hasConcept C181389837 @default.
• W4308694345 hasConcept C185592680 @default.
• W4308694345 hasConcept C19038510 @default.
• W4308694345 hasConcept C2776091944 @default.
• W4308694345 hasConcept C2777171753 @default.
• W4308694345 hasConcept C2777468819 @default.
• W4308694345 hasConcept C2779877776 @default.
• W4308694345 hasConcept C515207424 @default.
• W4308694345 hasConcept C543025807 @default.
• W4308694345 hasConcept C55493867 @default.
• W4308694345 hasConcept C71924100 @default.
• W4308694345 hasConcept C98274493 @default.
• W4308694345 hasConcept C99830354 @default.
• W4308694345 hasConceptScore W4308694345C126322002 @default.
• W4308694345 hasConceptScore W4308694345C134018914 @default.
• W4308694345 hasConceptScore W4308694345C181389837 @default.
• W4308694345 hasConceptScore W4308694345C185592680 @default.
• W4308694345 hasConceptScore W4308694345C19038510 @default.
• W4308694345 hasConceptScore W4308694345C2776091944 @default.
• W4308694345 hasConceptScore W4308694345C2777171753 @default.
• W4308694345 hasConceptScore W4308694345C2777468819 @default.
• W4308694345 hasConceptScore W4308694345C2779877776 @default.
• W4308694345 hasConceptScore W4308694345C515207424 @default.

• next